Theriva Biologics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Theriva Biologics, Inc. (TOVX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $1.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-12
- Theriva Biologics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $1.00K, a 0.00% change from fiscal 2024.
- Theriva Biologics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $1.00K, a 99.10% decline from fiscal 2023.
- Theriva Biologics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $111.00K, a 74.83% decline from fiscal 2022.
- Theriva Biologics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $441.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.00K 10-K · filed 2026-03-12 | |
| 2024-12-31 | $1.00K 10-K · filed 2026-03-12 | $181.00K 10-K · filed 2025-03-06 |
| 2023-12-31 | $111.00K 10-K · filed 2025-03-06 | |
| 2022-12-31 | $441.00K 10-K · filed 2024-03-25 | |
| 2019-12-31 | $0.00 10-K · filed 2020-02-20 | |
| 2018-12-31 | -$1.05M 10-K · filed 2020-02-20 | |
| 2017-12-31 | -$4.08M 10-K · filed 2019-02-27 | |
| 2016-12-31 | -$4.33M 10-K · filed 2018-02-22 | |
| 2015-12-31 | $1.45M 10-K · filed 2017-03-02 | |
| 2014-12-31 | -$235.00K 10-K · filed 2016-03-10 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 | |
| 2012-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |